Electromed stock: buy or sell?
October 18th, 2019
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally.
Should I buy Electromed stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. That's why is so important to define your own trading plan that matches with your character as inversor. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with Electromed stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Electromed stock a buy?
Financial institutions and banks post stock ratings everyday.Unfortunately, we couldn't find any rating for ELMD stock for the last month.
Electromed stock analysis
Electromed shares rocketed 6.04% to $6.85 on Oct 18th.
Shares of Electromed rocketed an exceptional 6.04% and closed at $6.85. Since SMA100d and SMA200d crossed up on September/20, ELMD price climbed $0.62 per share (9.95%). Since August when ELMD stock price broke up the SMA200d line, it gained $1.53 (28.76%). ELMD shows a sign of strength in the short-term after finally breaking out above $6.82 on Monday and marking a new rising bottom.
Electromed skyrocketed a great 5.38% this week.
Price pattern shows an uptrend with two rising tops and bottoms, and now trading upwards to the $7.25 resistance. Since SMA20d and SMA40w crossed up late August, ELMD price climbed $1.65 per share (31.73%). Since late August when ELMD stock price broke up the SMA40w line, it gained $1.65 (31.73%).
Electromed stock price history
Electromed stock went public on August 13th, 2010 with a price of $4.051. Since then, ELMD stock surged a 69.10%, with an average of 7.70% per year. If you had invested right after ELMD's IPO a $1,000 in Electromed stock in 2010, it would worth $691.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Electromed stock historical price chart
ELMD stock reached 52-week highs at $7.33, and all-time highs 2017-09-20 with a price of 7.96.
Electromed stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we have not detected any price forecast for Electromed stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter publishing its last earnings report on February, Electromed . As soon as we get its posted EPS from the earnings report, we will extend this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual turnover report draw a brilliant gain of 10.97% to $28.70 million USD. Instead, its earnings margin (compared to sales) declined to 6.63%, that is $1.90 million. Electromed fiscal year ends in June, and to evaluate its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Electromed TTM sales up to December 2018 were $30.62 and earnings $1.96 million USD. When comparing this TTM figures with the last reported annuality, we can esteem Electromed business evolution since June 2018: Annual revenues up to December, compared to lastest yearly report, escalated a shining 6.70%. However, profit margin (net income/sales) remained stable at 6.63%.
|2013||$15 M||-||$-1.33 M-8.8%||-|
|2014||$15 M||1.66%||$-1.29 M-8.4%||-3.01%|
|2015||$19 M||26.44%||$1.09 M5.6%||-184.69%|
|2016||$23 M||18.46%||$2.21 M9.6%||102.52%|
|2017||$26 M||12.48%||$2.23 M8.6%||0.77%|
|2018||$29 M||10.97%||$1.90 M6.6%||-14.67%|
|TTM||$31 M||6.70%||$1.96 M6.4%||3.24%|
Quarterly financial resultsElectromed reported $8.01 M in revenues for 2018-Q4, a 10.12% up compared to previous quarter. Reported quarter income marked $0.38 M with a profit margin of 4.71%. Profit margin grew a 2.59% compared to previous quarter when profit margin was 2.12%. When comparing sales to same quarter last year, Electromed sales marked an amazing growth and climbed a 14.72%.
|2017-Q1||$7 M||-||$0.65 M9.7%||-|
|2017-Q2||$7 M||9.00%||$0.95 M13.0%||46.08%|
|2017-Q3||$6 M||-12.22%||$0.12 M1.9%||-87.20%|
|2017-Q4||$7 M||9.45%||$0.35 M5.0%||188.38%|
|2018-Q1||$7 M||1.52%||$0.31 M4.4%||-10.45%|
|2018-Q2||$8 M||16.22%||$1.12 M13.6%||257.83%|
|2018-Q3||$7 M||-11.71%||$0.15 M2.1%||-86.21%|
|2018-Q4||$8 M||10.12%||$0.38 M4.7%||144.66%|
Electromed ownershipWhen you are planning to buy shares of a stock, it's always worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Electromed, 18.47% of all outstanding shares are owned by its staff.
In case of Electromed stock, 25.93% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ELMD stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related stocks:
|Market cap||$57.9 M||$5.6 M||$6.8 B||$1.1 B||$7.9 B|
|Total shares||8.5 M||4.0 M||66.8 M||21.9 M||53.3 M|
|Float shares||6.6 M||3.4 M||66.6 M||18.2 M||49.2 M|
|- Institutional holdings (%)||25.9%||11.2%||86.3%||109.7%||84.4%|
|- Insider holdings (%)||18.5%||62.9%||0.1%||1.2%||8.8%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Friday, October 18th, 2019|
|Day range||$6.67 - $7.00|
|Average true range||$0.31|
|50d mov avg||$5.98|
|100d mov avg||$5.66|
|200d mov avg||$5.55|
Electromed performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. In the following table, we compare Electromed performance to Allied Healthcare Products, Hill-Rom, Inogen, Masimo, Merit Medical Systems, ResMed and XTL Biopharmaceuticals:
|MMSIMerit Medical Sys...||-44.31%||-46.86%||-51.15%|